• Login
  • Register
Nairametrics
  • Home
  • Exclusives
    • Recapitalization
      • Access Holdings Offer
      • Fidelity Bank Offer
      • GTCO Offer
      • Zenith Bank Offer
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Nairalytics
  • Economy
    • Business News
    • Budget
    • Public Debt
    • Tax
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Public Offer & Right Issues
      • Stock Market News
    • Fixed Income
    • Funds Management
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Market Views
    • Op-Eds
    • Research Analysis
  • Home
  • Exclusives
    • Recapitalization
      • Access Holdings Offer
      • Fidelity Bank Offer
      • GTCO Offer
      • Zenith Bank Offer
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Nairalytics
  • Economy
    • Business News
    • Budget
    • Public Debt
    • Tax
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Public Offer & Right Issues
      • Stock Market News
    • Fixed Income
    • Funds Management
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Market Views
    • Op-Eds
    • Research Analysis
Nairametrics
Home Business News Diaspora

UPDATE: US approves chloroquine as treatment for COV-19

Chike Olisah by Chike Olisah
March 19, 2020
in Diaspora
US government to ban WeChat and TikTok from app stores, Reasons why a record number of people are giving up their US citizenship, US approves chloroquine as treatment for coronavirus COVID-19, Nigeria U.S. Donald Trump-oil prices, My COVID- 19 illness, a blessing from God –Trump
Share on FacebookShare on TwitterShare on Linkedin

The United States Government has approved Chloroquine, an anti-malaria drug, for use as a treatment for the coronavirus disease.

This was disclosed by President Donald Trump during a white house task force briefing on Thursday.

During the briefing, the President said, ‘We’re going to be able to make that drug available almost immediately, and that’s where the FDA (Food and Drug Administration) has been so great,ā€ Trump told reporters.

MoreStories

FG summons South African envoy over xenophobic attacks on citizens

FG summons South African envoy over xenophobic attacks on citizens

May 3, 2026
Sweden, work permit

Sweden to extend residency, mandate income proof, language tests from June 2026Ā 

May 1, 2026

ā€œThey’ve gone through the approval process — it’s been approved. They took it down from many, many months to immediate. So we’re going to be able to make that drug available by prescription.ā€

Meanwhile, in a tweet chat on Bloomberg’s handle monitored by Nairametrics, the FDA says it has not approved Chloroquine for covid-19 use.

READ ALSO: COVID-19: 25 million will be jobless, as Recession looms

The FDA Commissioner Stephen Hahn pointed out that, although the drug has not yet been formally approved, access to it was being expanded so that authorities could gather more data. He said that it is referred to as compassionate use.

The FDA commissioner said, ā€œIf there is an experimental drug that is potentially available, a doctor could ask for that drug to be used in a patient. We have criteria for that and very speedy approval for that,ā€ said Hahn.

ā€œAs an example, many Americans have read studies and heard media reports about this drug chloroquine, which is an anti-malarial drug.

ā€œIt’s already approved, as the president said, for the treatment of malaria as well as an arthritis condition.

ā€œThat’s a drug that the president directed us to take a closer look at, as to whether an expanded use approach to that could be done to actually see if that benefits patients.ā€

READ MORE: Trump’s coronavirus test result out as US extends European travel ban

Chloroquine is a synthetic form of quinine, which has been used to treat malaria since the 1940s.

The drug has recently been used to treat coronavirus patients in China and in France, where some researchers said it showed great promise, though scientists agree that only more trials would determine if it really works and is safe.


Add Nairametrics on Google News
Follow us for Breaking News and Market Intelligence.
Tags: CoronavirusCoronavirusĀ outbreakCoronavirus pandemicCovid-19Donald J. TrumpOn the MoneyPresident Trump
Chike Olisah

Chike Olisah

Chike was a banker with over 11 years experience in retail and commercial banking, risk management, treasury portfolio management and relationship management. He also acquired some experience in financial management and do have some special interest in investment analysis and personal finance. He had stints with financial institutions like the former Intercontinental Bank and Fidelity Bank.

Next Post
Decline in oil price has affected Nigeria’s financial capacity, CBN

Foreign investors shun CBN as latest OMO bills record zero bids

Comments 1

  1. Sam Osei says:
    March 20, 2020 at 11:22 am

    It would have been better to say “Trump approves Chloroquine, an anti-malaria drug, for use as a treatment for the coronavirus disease.”

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Luis Figo
Luis Figo
rabafast
nairametrics




DUNS

Follow us on social media:

  • ABOUT US
  • CONTACT US
  • PRODUCTS
  • ANDROID APP
  • iOS APP
  • DISCLAIMER
  • CAREERS
  • PRIVACY POLICY

Ā© 2026 Nairametrics

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Social Media Auto Publish Powered By : XYZScripts.com
No Result
View All Result
  • Home
  • Exclusives
    • Recapitalization
      • Access Holdings Offer
      • Fidelity Bank Offer
      • GTCO Offer
      • Zenith Bank Offer
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Nairalytics
  • Economy
    • Business News
    • Budget
    • Public Debt
    • Tax
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Public Offer & Right Issues
      • Stock Market News
    • Fixed Income
    • Funds Management
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Market Views
    • Op-Eds
    • Research Analysis
  • Login
  • Sign Up

Ā© 2026 Nairametrics